T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1095-1098

  Ohta, Tomohiko ^a,b,d   Okamoto, Kazuki ^b   Isohashi, Fumihide ^b   Shibata, Kiyotaka ^c   Fukuda, Mamoru ^b   Yamaguchi, Susumu ^b   Xiong, Yue ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ISHINOMAKI SENSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIN B; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE H1; INTERLEUKIN 2; PROTAMINE KINASE; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CYCLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME SUBSTRATE; EUKARYOTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY;

ALTERNATIVE SPLICING; BASE SEQUENCE; BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; PROTAMINE KINASE; PROTEIN BINDING; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032521196     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Norbury, C., and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
2. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
3. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
4. De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D, O., and Kim, S-H. Crystal structure of cyclin-dependent kinase 2. Nature (Lond.), 363: 595-602, 1993.
5. Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J., and Pavletich, N. P. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature (Lond.), 376: 313-320, 1995.
6. 1 cyclin (Cln) function in yeast. Cell, 66: 1197-1206, 1991.
7. cdc2. Cell, 58: 833-846, 1989.
8. 0-arrestable cancer cell line. Exp. Cell Res., 225: 85-92, 1996.
9. Jenkins, C. W., and Xiong, Y. Immunoprecipitation and immunoblotting in cell cycle studies. In: M. Pagano (ed.), Cell Cycle: Materials and Methods, pp. 250-263. New York: Springer-Verlag New York, Inc., 1995.
10. Li, Y., Jenkins, C. W., Nichols, M. A., and Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9: 2261-2268, 1994.
11. INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell. 7: 1587-1599, 1996.
12. Lee, M. G., and Nurse, P. Complementation used to clone a human homolog of the fission yeast cell cycle control gene CDC2. Nature (Lond.), 327: 31-35, 1987.
13. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature (Lond.), 382: 325-331, 1996.
14. Breathnach, R., Benoist, C., O'Hare, K., Gannon, F., and Chambon, P. Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. Proc. Natl. Acad. Sci. USA, 75: 4853-4857, 1978.
15. Booher, R. N., Alfa, C. E., Hyams, J. S., and Beach, D. H. The fission yeast CDC2/CDC13/SUC1 protein kinase: regulation of catalytic activity and nuclear localization. Cell, 58: 485-497, 1989.
16. Draetta, D., Luca, F., Westendorf, J., Brizuela, L., Ruderman, J., and Beach, D. CDC2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell, 56: 829-838, 1989.
17. Ducommun, B., Brambilla, P., and Draetta, G. Mutation at sites involved in SUC1 binding inactivate CDC2. Mol. Cell. Biol., 11: 6177-6184, 1991.
18. Betticher, D. C., Thatcher, N., Altermatt, H. J., Hoban, P., Ryder, D. J., and Heighway, J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11: 1005-1011, 1995.
19. Sewing, A., Ronicke, V., Burger, C., Funk, M., and Muller, R. Alternative splicing of human cyclin E. J. Cell Sci., 107: 581-588, 1994.